Drug Intermediates are used as raw materials during the manufacture of bulk drugs, in other words pharmaceutical intermediates are chemical compounds which form the building blocks of the active pharmaceutical ingredient (API).
Drug Intermediates can also be referred to as the material produced at the time of synthesis of an active pharmaceutical ingredient (API). Drug intermediates are generally hygienically formulated. Superior grade raw materials are used for their production and these are applied in both the cosmetic and pharmaceutical industries.
Drug Intermediates |
||
Intermediates |
API |
CAS |
3,5-Bis(2-cyanoisopropyl) benzalcohol |
Anastrozole intermediates |
120511-88-8 |
7-Hydroxy-3,4-dihydro-2(1H)-quinolinone |
Aripiprazole intermediates |
22246-18-0 |
(2S,3S)-3-Amino-2-methyl-4-oxo-1-azetidinesulfonic acid |
Aztreonam intermediates |
80082-65-1 |
3-(4-Chlorophenyl)glutaric acid monoamide |
Baclofen intermediates |
1141-23-7 |
4-Cyano-3-trifluoromethyl aniline |
Bicalutamide intermediates |
654-70-6 |
4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine |
Bosentan intermediates |
150728-13-5 |
3-Bromoacetyl-5-chlorothiophene-2-sulfonamide |
Brinzolamide intermediates |
160982-11-6 |
2,3,4,6-tetrakis-O-trimethylsilyl-D-gluconolactone |
Canagliflozin intermediates |
32384-65-9 |
5-(4-Chlorobutyl)-1-cyclohexyl-1H-tetrazole |
Cilostazol intermediates |
73963-42-5 |
D-(+)-Methyl-alpha-(2-thienylethamino)(2-chlorophenyl) acetate HCl |
Clopidogrel intermediates |
141109-19-5 |
N-(4-Cyanophenyl)glycine |
Dabigatran intermediates |
42288-26-6 |
4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether |
Dapagliflozin intermediates |
461432-23-5 |
2-Butyl-3-(4-hydroxybenzoyl)-5-nitrobenzofuran |
Dronedarone intermediates |
141645-16-1 |
(S)-3-(Dimethylamino)-1-(thiophen-2-yl)-propan-1-ol |
Duloxetine intermediates |
132335-44-5 |
4-Chloro-2-trifluoroacetylaniline HCl hydrate |
Efavirenz intermediates |
173676-59-0 |
4-(Aminocarbonyl)-N-[(1,1-dimethylethoxy)carbonyl]-2,6-dimethyl-L-phenylalanine |
Eluxadoline intermediates |
623950-02-7 |
(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy] tetrahydro-furan |
Empagliflozin intermediates |
915095-89-5 |
(6,11-dihydro-5H-dibenzo[b,e]azepin-6-yl)methanamine fumarate |
Epinastine intermediates |
127785-96-0 |
Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5- carboxylate |
Febuxostat intermediates |
161798-01-2 |
2,5-Bis (2,2,2-trifluoroethoxy) benzoic acid |
Flecainide intermediates |
35480-52-5 |
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2- pyrimidineamine |
Imatinib intermediates |
152460-10-1 |
4-(2-Methoxyethyl)-phenol (4-MEP) |
Metoprolol intermediates |
56718-71-9 |
2-Diacetoxymethyl-5-nitrofuran |
Nitrofurantoin intermediates |
92-55-7 |
(E)-3α-hydroxy-6-ethylidene-7-keto-5β-cholan-24-oic acid (N-2) |
Obeticholic Acid intermediates |
1516887-33-4 |
2-Fluoro-5-((3-oxoisobenzofuran-1(3H)-ylidene)methyl) benzonitrile |
Olaparib intermediates |
763114-25-6 |
4-(1-Hydroxy-1-methylethyl)-2-propyl-1H-imidazole-5- carboxylic acid ethyl ester |
Olmesartan intermediates |
144689-93-0 |
Tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate |
Palbociclib intermediates |
571188-59-5 |
3-(2-Chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl- 4H-pyrido[1,2-a]pyrimidin-4-one |
Paliperidone intermediates |
130049-82-0 |
4-Isobutoxy benzylamine acetate |
Pimavanserin intermediates |
955997-89-4 |
5,6,7,7a-Tetrahydrothieno[3,2-c]pyridine-2(4H)-one HCl |
Prasugrel intermediates |
115473-15-9 |
Dibenzo[b,f][1,4]thiazepine 11-piperazynil 2HCl (DBTP) |
Quetiapine intermediates |
111974-74-4 |
Dimethyl acetylenedicarboxylate (DMADC) |
Raltegravir intermediates |
762-42-5 |
(2-Amino-5-bromo-phenyl)-(2-pyridyl)methanone |
Remimazolam intermediates |
1563-56-0 |
4-(4-Aminophenyl)morpholin-3-one |
Rivaroxaban intermediates |
438056-69-0 |
3-[(1S)-1-(Dimethylaminoethyl)]phenol |
Rivastigmine intermediates |
139306-10-8 |
2,6-Difluorobenzyl bromide |
Rufinamide intermediates |
85118-00-9 |
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazineHCl |
Sitagliptin intermediates |
762240-92-6 |
4-(3-Methylphenyl)amino-3-pyridinesulfonamide |
Torasemide intermediates |
72811-73-5 |
2-Dimethylamino-2-phenylbutan-1-ol |
Trimebutine intermediates |
39068-94-5 |
(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile |
Vildagliptin intermediates |
207557-35-5 |
N-[1-(S)-Ethoxycarbonyl-3-phenylpropyl]-L-alanine-N-carboxyanhydride |
Enalapril maleate intermediates |
84793-24-8 |
5-Amino-4,6-dichloro-2-methylpyrimidine |
Moxonidinum intermediates |
39906-04-2 |
2-(2-Methoxyphenoxy)ethylaminehydrochloride |
Carvedilol intermediates |
64464-07-9 |
(2S,3aS,7aS)-Octahydro-1H-indole-2-carboxylic acid |
Perindopril Erbumine intermediates |
80875-98-5 |
3-acetylthio-2-d-methylpropionyl-l-proline |
Captopril intermediates |
64838-55-7 |
4’-Methyl-2-Cyano-Biphenyl |
Valsartan,Losartan intermediates |
114772-53-1 |
4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-n-methylsulfonyl)amino]pyrimidine-5-yl-methanol |
Rosuvastatin Ca intermediates |
147118-36-3 |
L-(-)-Camphorsulfonic Acid |
Resolving agent |
35963-20-3 |
6-O-methyl-2`,4``-bis-O-(trimethylsilyl),9-[O-(1-ethoxy-1-methylethyl) oxime |
Clarithromycin |
119665-62-2 |
Cis-propenylphosphonic acid |
|
25383-06-6 |
Chlorocarbonyl liminostilben |
Carbamazepine |
33948-22-0 |
11-a-hydroxy canrenone methyl ester |
Eplerenone |
192704-56-6 |
Atorvastatin tert-Butyl Ester |
Atorvastatin Calcium |
134395-00-9/125971-95-1 |
4-Aminophenol |
Paracetamol |
123-30-8 |
Download Drug Intermediates List-Part1
Download Drug Intermediates List-Part2